We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.56%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$100B
AUM Growth
-$9.45B
(-8.6%)
Cap. Flow
-$5.83B
Cap. Flow
% of AUM
-5.81%
Top 10 Holdings %
Top 10 Hldgs %
31.76%
Holding
3,811
New
911
Increased
1,180
Reduced
974
Closed
681
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$3.97B |
| 2 |
Chevron
CVX
|
+$527M |
| 3 |
Apple
AAPL
|
+$449M |
| 4 |
Morgan Stanley
MS
|
+$426M |
| 5 |
Airbnb
ABNB
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.21B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.87B |
| 3 |
Walmart Inc
WMT
|
+$831M |
| 4 |
Amazon
AMZN
|
+$692M |
| 5 |
Eli Lilly
LLY
|
+$641M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Consumer Discretionary | 11.57% |
| 3 | Healthcare | 9.79% |
| 4 | Financials | 6.87% |
| 5 | Industrials | 5.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
The RMR Group
RMR
$342M
| $1.55M | ﹤0.01% |
+100,058
| New | +$1.62M |
|
1902
Cartesian Therapeutics
RNAC
$232M
| $1.54M | ﹤0.01% |
251,115
+72,975
| +41% | +$520K |
|
1903
National Bank Holdings
NBHC
$1.93B
| $1.54M | ﹤0.01% |
+39,407
| New | +$1.58M |
|
1904
Luxfer Holdings
LXFR
$460M
| $1.54M | ﹤0.01% |
126,059
+104,270
| +479% | +$1.45M |
|
1905
Gorman-Rupp
GRC
$2.16B
| $1.53M | ﹤0.01% |
+24,661
| New | +$1.46M |
|
1906
Concrete Pumping Holdings
BBCP
$531M
| $1.53M | ﹤0.01% |
214,146
+187,993
| +719% | +$1.25M |
|
1907
Ceragon Networks
CRNT
$194M
| $1.53M | ﹤0.01% |
+707,171
| New | +$1.6M |
|
1908
Century Therapeutics
IPSC
$381M
| $1.52M | ﹤0.01% |
+673,584
| New | +$1.42M |
|
1909
Western Alliance Bancorporation
WAL
$9.07B
| $1.52M | ﹤0.01% |
21,472
+9,392
| +78% | +$783K |
|
1910
Lifestance Health
LFST
$4.16B
| $1.52M | ﹤0.01% |
237,927
-100,831
| -30% | -$702K |
|
1911
Dyne Therapeutics
DYN
$4.04B
| $1.51M | ﹤0.01% |
83,147
-593,832
| -88% | -$10.2M |
|
1912
Itaú Unibanco
ITUB
$91.3B
| $1.5M | ﹤0.01% |
179,355
-3,127,983
| -95% | -$26.2M |
|
1913
iShares Global Energy ETF
IXC
$2.78B
| $1.5M | ﹤0.01% |
+26,089
| New | +$1.3M |
|
1914
Americold
COLD
$4.09B
| $1.5M | ﹤0.01% |
+131,134
| New | +$1.64M |
|
1915
Ligand Pharmaceuticals
LGND
$6.02B
| $1.5M | ﹤0.01% |
+7,505
| New | +$1.48M |
|
1916
Liberty Media Series A
FWONA
$22.3B
| $1.5M | ﹤0.01% |
19,154
-4,935
| -20% | -$395K |
|
1917
Genie Energy
GNE
$378M
| $1.49M | ﹤0.01% |
105,469
+93,093
| +752% | +$1.32M |
|
1918
IBEX
IBEX
$448M
| $1.49M | ﹤0.01% |
55,539
-14,095
| -20% | -$456K |
|
1919
Johnson Controls International
JCI
$87.5B
| $1.49M | ﹤0.01% |
11,357
-42,543
| -79% | -$5.5M |
|
1920
Genesco
GCO
$396M
| $1.49M | ﹤0.01% |
51,296
-122,922
| -71% | -$3.53M |
|
|
OTGA
1921
OTG Acquisition Corp I
OTGA
$300M
| $1.49M | ﹤0.01% |
147,745
-77,255
| -34% | -$777K |
|
1922
Future Fuel
FF
$204M
| $1.48M | ﹤0.01% |
384,899
+231,021
| +150% | +$867K |
|
1923
L3Harris
LHX
$55.9B
| $1.48M | ﹤0.01% |
4,285
-73,139
| -94% | -$25.6M |
|
1924
Concentrix
CNXC
$1.36B
| $1.48M | ﹤0.01% |
53,994
-340,692
| -86% | -$12.1M |
|
|
VHCP
1925
Vine Hill Capital Investment Corp II
VHCP
$307M
| $1.47M | ﹤0.01% |
+148,959
| New | +$1.48M |
|
Similar funds
Marshall Wace's Q1 2026 Portfolio in Review
As of Q1 2026, Marshall Wace held 3,811 positions worth $100B, down 8.6% from $110B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Marshall Wace withdrew a net $5.83B in Q1 2026, closing 681 positions and reducing 974 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $2.87B position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Marshall Wace opened a new position in State Street SPDR Portfolio S&P 500 ETF worth $3.8B.
- Marshall Wace's largest Q1 2026 buy was State Street SPDR Portfolio S&P 500 ETF: 49,650,246 shares worth $3.8B.
- Marshall Wace added most to Chevron in Q1 2026, an estimated $527M increase.
- Marshall Wace's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $4.21B.
- Marshall Wace fully exited Vanguard S&P 500 ETF in Q1 2026, selling an estimated $2.87B.
- Marshall Wace's ten largest holdings make up 32% of its $100B portfolio in Q1 2026.
- Marshall Wace opened 911 new positions and closed 681 in Q1 2026.
- Marshall Wace's portfolio value fell 8.6% quarter-over-quarter to $100B.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.